Effect of human urinary thrombomodulin on endotoxin-induced intravascular coagulation and pulmonary vascular injury in rats

American Journal of Hematology

Volumn 54, Issue 2, 1997, Pages 118-123

  Uchiba, Mitsuhiro ^a   Okajima, Kenji ^a   Murakami, Kazunori ^a   Johno, Masayoshi ^a   Okabe, Hiroaki ^a   Takatsuki, Kiyoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

activated leukocytes; activated protein C; adult respiratory distress syndrome; disseminated intravascular coagulation; sepsis; urinary thrombomodulin

Indexed keywords

ENDOTOXIN; THROMBIN INHIBITOR; THROMBOMODULIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; DISSEMINATED INTRAVASCULAR CLOTTING; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE; LUNG EDEMA; LUNG INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY DISTRESS SYNDROME; SEPSIS;

EID: 0031056525     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-8652(199702)54:2<118::aid-ajh4>3.0.co;2-%23     Document Type: Article

References (34)

1. Bone RC, Maunder R, Slotman G, Silverman H, Hyers TM, Kerstein MD, Ursprung JJ: An early test of survival in patients with the adult respiratory distress syndrome. Chest 96:849-851, 1989.
2. Bone RC, Balk R, Slotman G, Maunder R, Silverman H, Hyers TM, Kerstein MD: Adult respiratory distress syndrome. Sequence and importance of development of multiple organ failure. Chest 101:320-326, 1992.
3. Kaplan JE, Malik AB: Thrombin-induced intravascular coagulation: Role in vascular injury. Semin Thromb Hemost 13:398-415, 1987.
4. Cooper JA, Solano SJ, Bizios R, Kaplan JE, Malik AB: Pulmonary neutrophil kinetics after thrombin-induced intravascular coagulation. J Appl Physiol 57:826-832, 1984.
5. Bone RC, Francis PB, Pierce AK: Intravascular coagulation associated with the adult respiratory distress syndrome. Am J Med 61:585-589, 1986.
6. Hasegawa N, Husari AW, Hart WT, Kandra TG, Raffin TA: Role of the coagulation system in ARDS. Chest 105:268-277, 1994.
7. St. John RC, Dorinsky PM: Immunologic therapy for ARDS, septic shock, and multiple organ failure. Chest 103:932-943, 1993.
8. Esmon NL, Owen WG, Esmon CT: Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 257:859-864, 1982.
9. Suzuki K, Stenflo J, Dahlback B, Teodorsson B: Inactivation of human coagulation factor V by activated protein C. J Biol Chem 258:1914-1920, 1983.
10. Vehar GA, Davie EW: Preparation and properties of bovine factor-VIII (antihemophilic factor). Biochemistry 19:401-410, 1980.
11. Fouw NJ, Jong YE, Haverkate F, Bertina RM: Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor - No evidence for a cofactor role of protein S. Thromb Haemost 60:328-333, 1988.
12. Moore KL, Esmon CT, Esmon NL: Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73:159-165, 1989.
13. Ishii H, Majerus PW: Thrombomodulin is present in human plasma and urine. J Clin Invest 76:2178-2181, 1985.
14. Jackson DE, Tetaz TJ, Salem HH, Mitchell CA: Purification and characterization of two forms of soluble thrombomodulin from human urine. Eur J Biochem 221:1079-1087, 1994.
15. Takahashi Y, Hosaka Y, Niina H, Nagasawa K, Naotsuska M, Sakai K, Uemura A: Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo. Thromb Haemost 73:805-811, 1995.
16. Bajaj SP, Rapaport SI, Prodanos CA: A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 11:397-412, 1981.
17. Morita T, Jackson CM: Localization of the structural difference between bovine blood coagulation factor XI and X2 to tyrosine 18 in the activation peptide. J Biol Chem 261:4008-4014, 1986.
18. Nesheim ME, Kettner C, Shaw E, Mann KG: Cofactor dependence of factor Xa incorporation into the prothrombinase complex. J Biol Chem 256:6537-6540, 1981.
19. Uchiba M, Okajima K, Murakami M, Nawa K, Okabe H, Takatsuki K: Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats. Thromb Haemost 74:1265-1270, 1995.
20. Chang SW: Endotoxin-induced pulmonary leukostasis in the rat: Role of platelet-activating factor and tumor necrosis factor. J Lab Clin Med 123:65-72, 1994.
21. Clauss A: Rapid physiological coagulation method for the determination of fibrinogen. Acta Haematol (Basel) 17:237-246, 1957.
22. Okajima K, Ueyama H, Hashimoto Y, Sasaki Y, Matsumoto K, Okabe H, Inoue M, Araki S, Takatsuki K: Homozygous variant of antithrombin III that lacks affinity for heparin: AT III Kumamoto. Thromb Haemost 61:20-24, 1989.
23. Murakami K, Okajima K,Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K: Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87:642-647, 1996.
24. Kumada T, Dittman WA, Majerus PW: A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice. Blood 71:728-733, 1987.
25. Gonda Y, Hirata S, Saitoh K, Aoki Y, Mohri M, Gomi K, Sugihara T, Kiyota T, Yamamoto S, Ishida T, Maruyama I: Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. Thromb Res 71:325-335, 1993.
26. Mohri M, Oka M, Aoki Y, Gonda Y, Hirata S, Gomi K, Kiyota T, Sugihara T, Yamamoto S, Ishida T, Maruyama I: Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats. Am J Hematol 45:298-303, 1994.
27. Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K: Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats. Thromb Res 78:117-125, 1995.
28. Taylor FB Jr, Chang ACK, Peer GT, Mather T, Blick K, Catlett R, Lockhart MS, Esmon CT: DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood 78:364-368, 1991.
29. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE: Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 79:918-925, 1987.
30. Snow TR, Deal MT, Dickey DT, Esmon CT: Protein C activation following coronary artery occlusion in the in situ porcine heart. Circulation 84:293-299, 1991.
31. Esmon CT, Taylor FB Jr, Snow TR: Inflammation and coagulation: Linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 66:160-165, 1991.
32. Hancock WM, Tsuchida A, Hau H, Thomson NM, Salem HH: The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapy. Transplant Proc 24:2302-2303, 1992.
33. Grey S, Hau H, Salem HH, Hancock WW: Selective effects of protein C on activation of human monocytes by lipopolysaccharide, interferonγ, or PMA: Modulation of effects on CD11b and CD14 but not CD25 or CD54 induction. Transplant Proc 25:2913-2914, 1993.
34. Grinnel BW, Hermann RB, Yan SB: Human protein C inhibits selectin-mediated cell adhesion: Role of unique fucosylated oligosaccharide. Glycobiology 4:221-225, 1994.